A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects
Clinical trial NCT01882322 · COMPLETED
Trial details
- NCT number
- NCT01882322
- Sponsor
- Astellas Pharma Korea, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-30
- Primary completion
- 2017-01-03
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.